About Rheogene
Rheogene is a company based in Norristown (United States) founded in 2003 was acquired by UPMC in February 2004. Rheogene operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Norristown, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Rheogene
Detailed funding history for Rheogene
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Rheogene
Rheogene has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include UPMC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multispecialty hospitals are operated as a nationwide chain.
|
Locked | Locked | Locked |
Investor details for Rheogene
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rheogene
Investment portfolio details for Rheogene
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Rheogene
Detailed financials for Rheogene
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rheogene Comparisons
Peer comparison for Rheogene
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Rheogene
Rheogene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases are developed to treat patients.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
Provider of cell therapies to treat cancer and hematologic conditions
|
Detailed competitors of Rheogene
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rheogene
Complete news archive for Rheogene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rheogene
Rheogene was founded in 2003.
Rheogene is headquartered in Norristown, United States. It is registered at Norristown, Pennsylvania, United States.
Rheogene was founded in 2003 and is headquartered in Norristown, United States. Operations focus on biotechnology, specifically the development of gene-based therapeutic products. The RheoSwitch therapeutic system and direct recombinase platform are utilized to modulate gene expression, supported by the Ultravector system. Applications include cellular and gene therapies, enhanced protein expression, and genomics research. Services are provided through these proprietary technologies.
Rheogene's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Rheogene has 1 investor. Key investors include UPMC.